IL13 and asthma: So far, asthma therapy uses drugs which alleviate the symptoms but do not inhibit the mechanism responsible for the expression of inflammatory mediators such as the cytokines interleukin-4 (IL-4), interleukin-13 (IL-13) and interleukin-5 (IL-5) [93,94].